Unknown

Dataset Information

0

Metastatic Renal Cell Cancer-Systemic Therapy.

ABSTRACT: Management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the past 10 years due to better understanding of tumor biology. This development has changed mRCC to a chronic progressive disease with several lines of treatment options. The introduction of several new targeted therapies including immunotherapy has improved median overall survival of approximately 1 year to >2 years in mRCC.

SUBMITTER: Joshi A 

PROVIDER: S-EPMC5856703 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Metastatic Renal Cell Cancer-Systemic Therapy.

Joshi Amit A   Sahu Arvind A   Noronha Vanita V   Patil Vijay V   Prabhash Kumar K  

Indian journal of surgical oncology 20180129 1

Management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the past 10 years due to better understanding of tumor biology. This development has changed mRCC to a chronic progressive disease with several lines of treatment options. The introduction of several new targeted therapies including immunotherapy has improved median overall survival of approximately 1 year to >2 years in mRCC. ...[more]

Similar Datasets

Unknown Systematic Review: Perioperative Systemic Therapy for Metastatic Renal Cell Carcinoma.
| S-EPMC6179116 | biostudies-literature
Unknown Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting.
| S-EPMC4654640 | biostudies-literature
Unknown Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.
| S-EPMC4167832 | biostudies-literature
Unknown Sequential Therapy in Metastatic Renal Cell Carcinoma.
| S-EPMC5345527 | biostudies-other
Unknown Combination therapy for metastatic renal cell carcinoma.
| S-EPMC4791344 | biostudies-literature
Unknown Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
| S-EPMC7647381 | biostudies-literature
Unknown Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy.
| S-EPMC5564792 | biostudies-literature
Unknown Axitinib in sequential therapy in metastatic renal cell carcinoma.
| S-EPMC5371698 | biostudies-other
Unknown Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis.
| S-EPMC7889529 | biostudies-literature
Unknown Systemic Therapy in Metastatic Melanoma.
| S-EPMC6375453 | biostudies-literature